Goldman Sachs’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-18,140
Closed -$172K 4407
2019
Q3
$172K Buy
+18,140
New +$172K ﹤0.01% 3947